Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z4RZ
|
|||
| Former ID |
DNC013797
|
|||
| Drug Name |
Adamant-1-ylcarbamic Acid Biphenyl-3-yl Ester
|
|||
| Synonyms |
CHEMBL485883; Adamant-1-ylcarbamic Acid Biphenyl-3-yl Ester
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C23H25NO2
|
|||
| Canonical SMILES |
C1C2CC3CC1CC(C2)(C3)NC(=O)OC4=CC=CC(=C4)C5=CC=CC=C5
|
|||
| InChI |
1S/C23H25NO2/c25-22(24-23-13-16-9-17(14-23)11-18(10-16)15-23)26-21-8-4-7-20(12-21)19-5-2-1-3-6-19/h1-8,12,16-18H,9-11,13-15H2,(H,24,25)
|
|||
| InChIKey |
STNJKWWAIGCDRW-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl a... J Med Chem. 2008 Jun 26;51(12):3487-98. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.